Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status.

Restriction landmark genomic scanning for methylation (RLGS-M) was used to detect, and subsequently clone, genomic regions with alterations in DNA methylation associated with tumorigenesis. Use of a methylation-sensitive enzyme for the landmark cleavage allows analysis of changes in methylation patterns. In this study, we used RLGS-M to analyze SV40 T antigen-induced mouse liver tumors derived from interspecific F1 hybrids between Mus spretus (S) and C57BL/6 (B6). Because 575 S- and B6-specific RLGS loci/spots have been mapped, tumor-related alterations in the RLGS profile could be immediately localized to specific chromosomal regions. We previously found that the loss of contiguous loci/spots could be attributed primarily to DNA loss, whereas loss of solitary loci/spots could be attributed primarily to DNA methylation. In this study, we examined 30 mouse liver tumor samples for loss of the 507 mapped loci/spots. Fourteen solitary loci/spots found to be absent or reduced in more than 75% of tumor samples were cloned and subjected to DNA sequence analyses. Two loci were identified as alpha4 integrin and p16/CDKN2, genes reported to be involved in tumorigenesis. Thus, RLGS-M can detect alterations in the methylation status of known tumor suppressor genes and provide a method for detecting and subsequently cloning novel genomic regions that undergo alterations in methylation during tumorigenesis.

[1]  W Arap,et al.  Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. , 1997, Cancer research.

[2]  Y. Hosoya,et al.  Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Lubahn,et al.  Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. , 1997, Cancer research.

[4]  G. Liang,et al.  Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. , 1997, Cancer research.

[5]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[6]  H. Hirai,et al.  Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1 , 1996, Molecular and cellular biology.

[7]  V. Chapman,et al.  Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS–M , 1996, Nature Genetics.

[8]  J. Bartek,et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.

[9]  S. Leung,et al.  Hypermethylation of the p16 gene in nasopharyngeal carcinoma. , 1996, Cancer research.

[10]  M. Berger,et al.  Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. , 1996, Cancer research.

[11]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.

[12]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[13]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[14]  Y. Okazaki,et al.  Loss of heterozygosity in chromosomes 1, 5, 7 and 13 in mouse hepatoma detected by systematic genome-wide scanning using RLGS genetic map. , 1995, Biochemical and biophysical research communications.

[15]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[16]  S. Baylin,et al.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.

[17]  Carissa A. Sanchez,et al.  Comparative genomic analysis of tumors: detection of DNA losses and amplification. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Rustum,et al.  Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. , 1994, Cancer research.

[19]  J. Shay,et al.  Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. , 1994, Cancer research.

[20]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Klein-Szanto,et al.  Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. , 1994, Cancer research.

[22]  I. Weissman,et al.  Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation , 1994, Cell.

[23]  A. Bird,et al.  Number of CpG islands and genes in human and mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Kawai,et al.  Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. , 1993, Nucleic acids research.

[25]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[26]  T. Sakai,et al.  CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. , 1993, Oncogene.

[27]  D. Sudar,et al.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. , 1992, Science.

[28]  E S Lander,et al.  A genetic map of the mouse suitable for typing intraspecific crosses. , 1992, Genetics.

[29]  Y. Hayashizaki,et al.  A genomic scanning method for higher organisms using restriction sites as landmarks. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Schirmacher,et al.  Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice. , 1991, The American journal of pathology.

[31]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[32]  B. Migeon.  Insights into X chromosome inactivation from studies of species variation, DNA methylation and replication, and vice versa. , 1990, Genetical research.

[33]  J. Mullins,et al.  T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene. , 1989, The EMBO journal.

[34]  Prateek Kulkarni,et al.  American Association for Cancer Research , 2004 .

[35]  Y. Hayashizaki,et al.  An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8) , 1995, Electrophoresis.

[36]  V. Chapman,et al.  A single gel analysis of 575 dominant and codominant restriction landmark genomic scanning loci in mice interspecific backcross progeny , 1995, Electrophoresis.

[37]  Y. Hayashizaki,et al.  A spot cloning method for restriction landmark genomic scanning , 1995, Electrophoresis.

[38]  V. Chapman,et al.  Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method , 1994, Nature Genetics.

[39]  Jun Kawai,et al.  Restriction landmark genomic scanning method and its various applications , 1993, Electrophoresis.

[40]  E. Stanbridge.  Human tumor suppressor genes. , 1990, Annual review of genetics.